Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
Table 1
Characteristics and outcome of patients in the series. Column “All patients” includes the whole series of patients with normal platelets or thrombocytosis. test between the group with normal platelet count and the group with thrombocytosis is shown. Wherever there are more than two categories, the grouping of the comparison is mentioned in the same column. Her-2 was defined as positive if 3+ by IHC or amplified by FISH and negative if 1+ by IHC or 2+ by IHC and FISH not amplified or not performed.